Impax Asset Management Group plc Lowers Stock Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Impax Asset Management Group plc cut its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 20.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 135,000 shares of the company’s stock after selling 35,000 shares during the quarter. Impax Asset Management Group plc owned 0.27% of Prestige Consumer Healthcare worth $10,542,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in PBH. Kestra Investment Management LLC acquired a new stake in Prestige Consumer Healthcare in the 4th quarter valued at $27,000. Huntington National Bank grew its position in shares of Prestige Consumer Healthcare by 39.9% in the third quarter. Huntington National Bank now owns 635 shares of the company’s stock valued at $46,000 after purchasing an additional 181 shares during the period. International Assets Investment Management LLC increased its stake in shares of Prestige Consumer Healthcare by 7,112.5% during the third quarter. International Assets Investment Management LLC now owns 1,154 shares of the company’s stock worth $83,000 after purchasing an additional 1,138 shares in the last quarter. Covestor Ltd raised its position in shares of Prestige Consumer Healthcare by 95.6% during the 3rd quarter. Covestor Ltd now owns 1,338 shares of the company’s stock worth $96,000 after purchasing an additional 654 shares during the last quarter. Finally, GAMMA Investing LLC lifted its stake in Prestige Consumer Healthcare by 18.9% in the 4th quarter. GAMMA Investing LLC now owns 1,383 shares of the company’s stock valued at $108,000 after buying an additional 220 shares in the last quarter. 99.95% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the company. Sidoti lowered Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price objective for the company. in a research note on Monday, December 9th. StockNews.com upgraded Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research report on Friday, January 24th. Canaccord Genuity Group raised their price objective on Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a “buy” rating in a report on Friday, February 7th. DA Davidson upped their target price on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the stock a “buy” rating in a report on Friday, February 7th. Finally, Raymond James raised shares of Prestige Consumer Healthcare to a “moderate buy” rating in a research note on Thursday, December 19th. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $92.60.

Prestige Consumer Healthcare Stock Up 0.6 %

Shares of PBH opened at $85.12 on Tuesday. The stock has a fifty day simple moving average of $79.53 and a two-hundred day simple moving average of $76.75. The company has a quick ratio of 2.20, a current ratio of 3.68 and a debt-to-equity ratio of 0.56. The company has a market capitalization of $4.22 billion, a PE ratio of 19.93, a price-to-earnings-growth ratio of 2.69 and a beta of 0.50. Prestige Consumer Healthcare Inc. has a 52-week low of $62.35 and a 52-week high of $88.36.

Prestige Consumer Healthcare (NYSE:PBH) last issued its earnings results on Thursday, February 6th. The company reported $1.22 EPS for the quarter, topping analysts’ consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. As a group, equities analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.